Close Menu

Enzo Biochem: Rebecca Fischer

Enzo Biochem has appointed Rebecca Fischer to its board of directors, effective immediately. Her appointment as an independent director follows a process as part of the company's focus on board compositions, refreshment, and diversity. Fisher's appointment, Enzo said, will be a valuable contribution to its women's health business. She replaces Gregory Bortz who retired from the board. Dov Perlysky, who has been on the board since 2012, will replace Bortz as lead independent director of Enzo. 

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

SARS-CoV-2 vaccine developers are evaluating further vaccine doses as well as modified doses to keep up with new viral variants, according to CNN.

The New York Times reports that a new viral variant of concern has been identified in New York City.

In Nature this week: spatiotemporally resolved map of the human cell cycle, folding single-cell RNA sequencing into cancer drug studies, and more.

CNN reports that a US Food and Drug Administration document says Johnson & Johnson's SARS-CoV-2 vaccine meets the requirements to receive an Emergency Use Authorization.